Filter by

Location

more »

Company

more »

We've found 6 jobs for you

larimar therapeutics  •  2026-06-05
  Philadelphia, US

Bureau Director, Bureau of Building Management

This publicly held clinical-stage biotechnology company is focused on developing treatments for patients suffering from complex rare diseases using its novel cell penetrating peptide technology platform. The company has between 60 and 70 employees and has asse…

larimar therapeutics  •  2026-06-03
  Philadelphia, US

Director, Business Development

Description: About Us: Larimar Therapeutics Inc. (Larimar) is a publicly held clinical-stage biotechnology company focused on developing treatments for patients suffering from complex rare diseases using its novel cell penetrating peptide technology platform. …

larimar therapeutics  •  2026-06-04
  Philadelphia, US

Vice President, Medical

Description: The Company:  This publicly held clinical-stage biotechnology company is focused on developing treatments for patients suffering from complex rare diseases using its novel cell penetrating peptide technology platform. Their lead product candidate…

larimar therapeutics  •  2026-06-05
  Philadelphia, US

Bureau Director, Bureau of Building Management

This publicly held clinical-stage biotechnology company is focused on developing treatments for patients suffering from complex rare diseases using its novel cell penetrating peptide technology platform. The company has between 60 and 70 employees and has asse…

larimar therapeutics  •  2026-06-04
  Philadelphia, US

Vice President, Medical

Description: The Company:  This publicly held clinical-stage biotechnology company is focused on developing treatments for patients suffering from complex rare diseases using its novel cell penetrating peptide technology platform. Their lead product candidate…

larimar therapeutics  •  2026-06-03
  Philadelphia, US

Director, Business Development

Description: About Us: Larimar Therapeutics Inc. (Larimar) is a publicly held clinical-stage biotechnology company focused on developing treatments for patients suffering from complex rare diseases using its novel cell penetrating peptide technology platform. …